Astsaturov; Igor

Patent Applications and Registrations

Patent applications and USPTO patent grants for Astsaturov; Igor.The latest application filed is for "c-myc as a biomarker for tumor sensitivity to treatment with rna polymerase ii inhibition".

Company Profile

2.5.8

Astsaturov; Igor - Philadelphia PA
Astsaturov, Igor - Baltimore MD

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
EGFR/NEDD9/TGF-.beta. interactome and methods of use thereof for the identification of agents having efficacy in the treatment of hyperproliferative disorders Grant 10,450,613 - Astsaturov , et al. Oc	2019-10-22
C-Myc as a biomarker for tumor sensitivity to treatment with RNA polymerase II inhibition Grant 10,328,050 - Astsaturov , et al.	2019-06-25
C-MYC As A Biomarker For Tumor Sensitivity To Treatment With RNA Polymerase II Inhibition App 20180263955 - Astsaturov; Igor ; et al.	2018-09-20
Method of treating MYC-amplified tumors with RNA-polymerase II inhibitors Grant 9,993,458 - Astsaturov , et al. June 12, 2	2018-06-12
Egfr/nedd9/tgf-beta Interactome And Methods Of Use Thereof For The Identification Of Agents Having Efficacy In The Treatment Of Hyperproliferative Disorders App 20170002426 - Astsaturov; Igor ; et al.	2017-01-05
C-MYC as a Biomarker for Tumor Sensitivity to Treatment with RNA Polymerase II Inhibition App 20160354339 - Astsaturov; Igor ; et al.	2016-12-08
Combination therapy based on SRC and aurora kinase inhibition for the treatment of cancer Grant 9,101,631 - Ratushny , et al. August 11, 2	2015-08-11
Egfr/nedd9/tgf-beta Interactome And Methods Of Use Thereof For The Identification Of Agents Having Efficacy In The Treatment Of Hyperproliferative Disorders App 20130331294 - Astsaturov; Igor ; et al.	2013-12-12
Combination Therapy Based on SRC and Aurora Kinase Inhibition for the Treatment of Cancer App 20110281935 - Ratushny; Vladimir ; et al.	2011-11-17
Combination Therapy for the Treatment of Cancer App 20110033461 - Ratushny; Vladimir ; et al.	2011-02-10
Egfr/nedd9/tgf-beta Interactome And Methods Of Use Thereof For The Identification Of Agents Having Efficacy In The Treatment Of Hyperproliferative Disorders App 20100239656 - Astsaturov; Igor ; et al.	2010-09-23
Vaccines using high-dose cytokines App 20040223949 - Astsaturov, Igor ; et al.	2004-11-11

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.